[HTML][HTML] Host-Targeted Therapeutics against Multidrug Resistant Intracellular Staphylococcus aureus

N Bravo-Santano, V Behrends, M Letek - Antibiotics, 2019 - mdpi.com
Staphylococcus aureus is a facultative intracellular pathogen that invades and replicates
within many types of human cells. S. aureus has shown to rapidly overcome traditional …

[图书][B] Staphylococcus aureus

LEL Yves, G Michel - 2009 - books.google.com
Staphylococcus aureus est une bactérie pathogène majeure pour l'Homme et les animaux à
sang chaud, tristement célèbre pour son exceptionnelle résistance aux traitements …

Therapeutic options and emerging alternatives for multidrug resistant staphylococcal infections

M Magana, A Ioannidis, E Magiorkinis… - Current …, 2015 - ingentaconnect.com
Methicillin-resistant Staphylococcus aureus (MRSA) remains the single biggest challenge in
infectious disease in the civilized world. Moreover, vancomycin resistance is also spreading …

[PDF][PDF] Alternative therapies in Staphylococcus aureus diseases

J Kurlenda, M Grinholc - Acta Biochimica Polonica, 2012 - bibliotekanauki.pl
Staphylococcus aureus is a common pathogen responsible for health-care-associated
infections as well as community acquired ones. It is the etiological factor of a wide spectrum …

Tips and Tricks from Staphylococcus Aureus

K van Kessel, KE Veldkamp, A Pesschel… - Tropical Diseases: From …, 2003 - Springer
Staphylococcus aureus is a normal commensal of the skin and mucous membranes. When
either of these two barriers are disrupted, the first and most important line of host defence …

Prevention of Staphylococcus aureus infections: advances in vaccine development

HR Shinefield, S Black - Expert Review of Vaccines, 2005 - Taylor & Francis
Staphylococcus aureus is a ubiquitous bacterial species that causes serious disease in a
minority of carriers, particularly in hospital settings. S. aureus disease is difficult to treat, and …

Virulence factor targeting of the bacterial pathogen Staphylococcus aureus for vaccine and therapeutics

TL Kane, KE Carothers, SW Lee - Current drug targets, 2018 - ingentaconnect.com
Background: Staphylococcus aureus is a major bacterial pathogen capable of causing a
range of infections in humans from gastrointestinal disease, skin and soft tissue infections, to …

[HTML][HTML] Toward an effective Staphylococcus vaccine: why have candidates failed and what is the next step?

CM Tsai, J Caldera, IA Hajam, GY Liu - Expert review of vaccines, 2023 - Taylor & Francis
S. aureus is a leading cause of infection and a major driver of antibiotic resistance.
Appropriately, it consistently ranks on the CDC list of 'THREAT'pathogens that are in dire …

[HTML][HTML] Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus

MR Yeaman, SG Filler, CS Schmidt… - Frontiers in …, 2014 - frontiersin.org
Recent perspectives forecast a new paradigm for future “third generation” vaccines based
on commonalities found in diverse pathogens or convergent immune defenses to such …

Staphylococcus aureus antigens and challenges in vaccine development

JR Middleton - Expert review of vaccines, 2008 - Taylor & Francis
Staphylococcus aureus is an important cause of nosocomial and community-acquired
infections in humans and animals, as well as mastitis in dairy cattle. Methicillin-resistant S …